How Some Viruses Cause Cancer
This is a modal window.
The media could not be loaded, either because the server or network failed or because the format is not supported.
Formal Metadata
Title |
| |
Title of Series | ||
Number of Parts | 340 | |
Author | ||
License | CC Attribution - NonCommercial - NoDerivatives 4.0 International: You are free to use, copy, distribute and transmit the work or content in unchanged form for any legal and non-commercial purpose as long as the work is attributed to the author in the manner specified by the author or licensor. | |
Identifiers | 10.5446/55133 (DOI) | |
Publisher | ||
Release Date | ||
Language |
Content Metadata
Subject Area | ||
Genre | ||
Abstract |
|
Lindau Nobel Laureate Meetings176 / 340
3
5
15
16
18
22
23
27
32
33
34
35
47
54
58
67
69
70
72
73
78
79
83
84
85
86
87
90
92
95
100
102
103
104
105
106
114
115
116
118
119
120
122
126
128
129
130
131
133
137
142
143
145
147
148
149
153
155
156
159
162
163
165
168
169
174
176
178
181
182
189
194
198
201
202
203
206
209
213
214
217
218
219
220
225
227
228
237
240
241
244
245
250
254
257
260
261
266
273
278
284
285
287
291
293
297
302
308
310
317
318
319
321
325
327
328
333
00:00
Meeting/Interview
00:40
Meeting/Interview
01:05
Meeting/Interview
01:29
Meeting/Interview
01:54
Meeting/Interview
02:19
Meeting/Interview
02:44
Meeting/Interview
03:09
Meeting/Interview
03:33
Meeting/Interview
03:58
Meeting/Interview
04:23
Meeting/Interview
04:48
Meeting/Interview
05:13
Meeting/Interview
05:37
Meeting/Interview
06:02
Meeting/Interview
06:27
Meeting/Interview
06:52
Meeting/Interview
07:17
Meeting/Interview
07:41
Meeting/Interview
08:06
Meeting/Interview
08:31
Meeting/Interview
08:56
Meeting/Interview
09:21
Meeting/Interview
09:45
Meeting/Interview
10:10
Meeting/Interview
10:35
Meeting/Interview
11:00
Meeting/Interview
11:25
Meeting/Interview
11:49
Meeting/Interview
12:14
Meeting/Interview
12:39
Meeting/Interview
13:04
Meeting/Interview
13:29
Meeting/Interview
13:53
Meeting/Interview
14:18
Meeting/Interview
14:43
Meeting/Interview
15:08
Meeting/Interview
15:33
Meeting/Interview
15:57
Meeting/Interview
16:22
Meeting/Interview
16:47
Meeting/Interview
17:12
Meeting/Interview
17:37
Meeting/Interview
18:01
Meeting/Interview
18:26
Meeting/Interview
18:51
Meeting/Interview
19:16
Meeting/Interview
19:41
Meeting/Interview
20:05
Meeting/Interview
20:30
Meeting/Interview
20:55
Meeting/Interview
21:20
Meeting/Interview
21:45
Meeting/Interview
22:09
Meeting/Interview
22:34
Meeting/Interview
22:59
Meeting/Interview
23:24
Meeting/Interview
23:49
Meeting/Interview
24:13
Meeting/Interview
24:38
Meeting/Interview
25:03
Meeting/Interview
25:28
Meeting/Interview
25:53
Meeting/Interview
26:17
Meeting/Interview
26:42
Meeting/Interview
27:07
Meeting/Interview
27:32
Meeting/Interview
27:57
Meeting/Interview
28:21
Meeting/Interview
28:46
Meeting/Interview
29:11
Meeting/Interview
29:36
Meeting/Interview
30:01
Meeting/Interview
30:25
Meeting/Interview
30:50
Meeting/Interview
Transcript: English(auto-generated)
00:11
As you can tell by the previous talks, oncogenes seem to be everywhere,
00:20
both in us and in biological research now. I am going to talk on a similar topic to the last speaker and tell you about the development of the idea of oncogenes and proto-oncogenes
00:44
and how this work originally with animal viruses in non-human hosts led to our appreciation of the genetic mechanisms in all cancers.
01:04
There are known viruses involved in human cancer. These are listed on the first slide, if I could get it. These include the DNA viruses, Epstein-Bor virus related to Burkitt's lymphoma
01:27
and nasopharyngeal carcinoma, the hepatitis B virus involved in primary hepatocellular carcinoma, and the recently described human retroviruses HTLV-ATLV involved in adult T cell lymphoma.
01:48
However, in the majority of human cancers in the developed countries, viruses like these are not important, but other factors like cigarette smoking,
02:03
radiation, various undefined life cycle factors are responsible for the development of most cancers. However, the study of cancer by viruses called highly oncogenic retroviruses
02:22
has been avidly pursued for a great number of years because of the very simple ability of these viruses to cause cancer. In contradistinction to the usual multistage nature of carcinogenesis,
02:40
these viruses can infect a normal cell and in a single step change the normal cell into a cancer cell. The viruses that can do this differ from normal viruses. Normal viruses either have DNA as their genetic material
03:04
and replace the genetic material of the cell with the viral DNA or, and could you focus the bottom of the slide please, or they have viral RNA as their genetic material. Viral RNA which replicates without the use of a DNA intermediate.
03:27
Most of the viruses which infect us are of this type herpes virus and this type cold viruses, measles virus, so forth. The viruses which are able to cause cancer in this very rapid faction
03:45
are known as retroviruses because they reverse the usual flow of information. Instead of information just flowing from DNA to RNA to proteins, in the case of the retroviruses the information flows in reverse from RNA to DNA.
04:06
This DNA then is added to cell DNA and multiplies as a cell gene with the cell DNA. The virus is able to do this because of three remarkable genes in the virus.
04:29
Here we are looking at a diagram of the virus life cycle with viral RNA indicated as this string.
04:42
This viral RNA acts as a template. Here we are looking at the genome in DNA and this gene called polymerase, PAL, codes for an enzyme known as reverse transcriptase
05:00
which using specific primers is able to transcribe this RNA into a linear DNA copy. The linear DNA copy contains at both ends signified by the open boxes a large terminal repeat with a small inverted repeat.
05:23
These are the other viral genes. This process takes place in the cytoplasm in a very specific manner involving double jumps of the DNA polymerase complex. The linear unintegrated viral DNA is then transported to the nucleus
05:44
where it is circularized by blunt end ligation so that the two ends of the linear DNA are juxtaposed making a circle junction.
06:00
This circle junction then contains an inverted repeat by putting this inverted repeat next to that one. The PAL gene in addition to coding for reverse transcriptase at its three prime end codes for another activity which we call int for integrase
06:23
though this is not yet proven. And this activity acts on the circle junction sequence which we have called at for attachment to remove four base pairs in the center and then to covalently insert the viral DNA
06:45
as a collinear copy minus two bases on each end into the cell DNA. At the same time this enzyme or another enzyme unknown brings about a direct duplication of sequences in the cell DNA.
07:08
So the virus contains an extremely specific and efficient machinery that is able to take external information in the form of RNA
07:25
and add it to cell DNA as a covalent copy. I am not, because of what I was asked to do today, not going to tell you more of the details of this process
07:45
though I would be glad to discuss it with anyone who is interested this afternoon. So the first special features of retroviruses that enable them to cause cancer in such an efficient manner
08:02
are their ability to make a DNA copy of RNA and then to add this DNA into the cell genome where it becomes a cell gene, an external gene into a cell gene. Next slide.
08:22
Automatic projectors work better sometimes. Now we are looking again at a cartoon of the genome of the virus with at the ends the open boxes referring to this large terminal repeat known as LTR
08:44
and in the middle instead of the genes I have just written viral coding sequences. The sequences coding for the proteins of the virus including those for the coat and those responsible for reverse transcription and integration.
09:04
And here I have enlarged the end of the viruses. So these large boxes are now the repeat. I have indicated here at the very ends the at sequences which we have discussed
09:21
as being responsible for the integration of the virus. In addition there are many other specific sequences in the LTR and nearby here and here responsible for control of RNA and DNA synthesis
09:40
of the virus. And finally there is a sequence here known as E for encapsulation which is responsible for telling the viral proteins to encapsulate the viral RNA into a virus particle.
10:03
So we can see that in the virus there has been a segregation of its sequences with the viral coding sequences in the center and the sequences which control the virus which we speak of as cis-acting sequences
10:22
since they act directly on the nucleic acid to which they are attached as compared to these sequences we speak of as trans-acting because their product can act on separated molecules. These are segregated with the trans-acting coding sequences
10:41
in the center, the cis-acting sequences at the end. Now some of these viruses can cause cancer very rapidly and efficiently. This is an example of a chicken injected two weeks earlier with one of these viruses
11:02
and the chicken is dead of a fulminating leukemia. This is an example in cell culture of a cell infected ten days previously by a virus and transformed into a cancer cell seen here on the dish.
11:26
Now when we look at the structure of viruses able to bring about this very rapid transformation we find, and an example of one of these is shown at the bottom,
11:41
we find that the structure of the virus is very different from the structure of the viruses I have been talking about. In these top viruses which we call replication-competent viruses we see the familiar open boxes of the large terminal repeat.
12:03
Here various cis-acting sequences responsible for DNA synthesis and encapsulation and the three genes coding for viral proteins. In the highly oncogenic retrovirus we see that the terminal sequences at each end are the same.
12:24
In other words the highly oncogenic retrovirus maintains the cis-acting sequences responsible for RNA and DNA synthesis and encapsulation of viral RNA.
12:40
But it has sustained a deletion of coding sequences and a substitution of new sequences. To establish the role of these new sequences we carry out genetic experiments using techniques of recombinant DNA
13:01
which allows us to make specific deletions in viral genomes and then using transfection of animal cells related to the transformation process described by Dr. Smith we can recover the viruses
13:23
and ask if they're still capable of causing cancer. Here we have the genome of one of these highly oncogenic retroviruses containing the new sequences, the deletion and other viral sequences. If we delete more of the viral sequences
13:44
and it's best to look at this construct so that all that is left are the cis-acting sequences at both ends and the new substituted sequences we see the virus still transforms.
14:01
However if we maintain the viral sequences and make any kind of an alteration in the substituted sequences the viruses which are recovered are no longer tumorigenic. This is the strict definition of an oncogene.
14:23
An oncogene or oncogenes are genes in highly oncogenic retroviruses that code for protein product required for neoplastic transformation. Similar types of experiments have been carried out with about 20 different viruses
14:44
and about 20 different oncogenes have been recognized all from their appearance in retroviruses and their ability then to transform normal cells to neoplastic cells
15:01
after addition to the cell genome by retrovirus infection. Of course you can't read them and the names SARC, YES, FIPS, FES, ABLE, ROS, FIGURE, ER, MIMS, MAS, RAS, RAS, MCMIB, FAST, RAF, SKE, REL and CIS
15:21
are merely three-letter mnemonics. Listed here are the species of origin of the viruses. They have been found in chickens, cats, mice, rats, turkey and monkey and in some case the same oncogene has been isolated from a virus
15:42
from two different species. Furthermore, the oncogenes are clustered into groups on the basis of similarities in sequence and function so that these six oncogenes all have a tyrosine protein kinase activity.
16:02
These three have no such activity but have a DNA sequence related to SARC. These two are related by sequence and by protein making a GTP binding activity. These have a nuclear location and these have unknown functions and locations.
16:26
So we see that viral oncogenes are not an infinite set but are actually a small set with the same gene being isolated repeatedly from different species
16:44
and furthermore we see that even the different viral oncogenes fall into related families. So this tells us that at least from this definition of oncogene that only a small number, somewhere we would guess less than 40 genes
17:06
are able to be turned into these powerful cancer genes and not any kind of a gene can become a cancer gene. Now as Professor Ochoa indicated the viral oncogene
17:26
comes from a normal cell gene known as proto-oncogene. In a number of steps a retrovirus picks up the cell DNA and makes it into an oncogene.
17:42
This is again a specific cartoon comparing a replication-competent virus, the highly oncogenic retrovirus and a proto-oncogene whose sequence is homologous to the sequence of the viral oncogene.
18:05
And you can immediately see that the proto-oncogene does not resemble the viral oncogene. The proto-oncogene is split into exons and introns.
18:21
The proto-oncogene has its own promoter and three prime sequences while the viral oncogene uses the viral promoter and termination sequences. The proto-oncogene is expressed in normal cells
18:40
and as I guess Dr. Holley told you, at times can have a very important function controlling normal cell growth. So the proto-oncogenes are a cell gene whose DNA sequences are homologous to viral oncogenes.
19:03
And so as there are 20 to 40 oncogenes we imagine, there are only 20 to 40 proto-oncogenes, normal cell genes whose mutation in the way of transduction by a retrovirus can cause cancer.
19:26
Now what is the difference between the proto-oncogene which does not cause cancer and the viral oncogene which does cause cancer?
19:41
I have already indicated to you that there is a very big difference in regulation because in the one case the proto-oncogene is controlled by cell transcriptional control signals. In the case of the oncogene the expression is controlled by viral transcriptional controls.
20:08
Furthermore, when the sequences are compared of the protein produced by the proto-oncogene which is illustrated by the heavy black line as if the amino acid sequence was written out
20:26
and since this is the normal homolog, the precursor is written out as a continuous bar when this is compared with the protein sequence of the viral oncogene
20:44
indicated here with circles, Xs, triangles and thin lines we see there are numerous differences. First we'll look at the similarities. Wherever the thin line is continuous the proteins are the same.
21:06
Wherever there are triangles, there are amino acid differences in the middle of the protein and the Xs at the end and the circles and Xs at the beginning
21:22
indicate that the viral oncogene uses sequences from the virus to code the amino and carboxy termini of its protein. In other words, the proto-oncogene has been severely modified on becoming a viral oncogene.
21:48
It has had its regulation changed by losing its own control sequences and having viral control sequences. It has changed the ends of its protein molecule
22:04
and it has changed some amino acids in the middle. Now these are correlational changes. I'm just going to indicate to you this one kind of experiment
22:20
which tells you how we determine which of these changes are significant in the transforming process. Again, there is an enormous amount more I could tell you about this but this is just to indicate how these are done.
22:41
Again, we're looking at viral genomes with the boxes and the lines representing the cis-acting sequences which are all the same at the end. These are now what we call retrovirus vectors where we've removed all the virus coding sequences and in this case replace them with the thymidine kinase gene
23:05
or viral oncogenes or cellular proto-oncogene. So these are highly oncogenic-like viruses that have been constructed as we say by cut and paste in the laboratory
23:21
where we make viruses at will, viruses of different kinds for different purposes. Now the purpose here is to look at two of these, this one and this one. This one contains a viral oncogene, the Harvey Rast gene.
23:41
The virus is produced in good yield. It is able to transform normal chicken cells immediately upon infection but it is not able to transform rat cells even though the virus is present in the rat cells
24:02
and the gene in the virus is expressed at a low level. This difference is related to the regulation of the gene activity. The viral promoters are very active in chicken cells
24:21
but these particular virus promoters are not active in rat cells. In that case, there is not sufficient product of the oncogene to transform the cells. Similarly, I will tell you but not illustrate
24:40
with other viral oncogenes if the oncogene is expressed at a high level, the cells are killed and it is only when the oncogene is expressed at a low level that the cells are transformed. Thus, we can conclude experimentally
25:01
that the change in regulation has been important in the transforming process. We speak of this as a quantitative change. Now at the bottom, we are looking at a similar construct for various technical reasons, there had to be a deletion
25:21
involving the proto-oncogene which as Dr. Ochoa told you, just differs in a single amino acid from the viral oncogene. Again, the virus is recovered at full yield but it is unable to transform chicken cells
25:41
even though the viral oncogene can transform them. Thus, this experiment indicates that even when there is misregulation of the normal cell gene, it is unable to transform the cells.
26:01
Thus, we can answer the question of our title how some viruses cause cancer that highly oncogenic retroviruses cause cancer by introducing, by adding to the genomes of sensitive target cells at new locations
26:22
a quantitatively and qualitatively altered cellular gene. The cellular gene is the proto-oncogene, it is qualitatively altered by base pair mutations and fusion with viral coding sequences,
26:40
it is quantitatively altered by being under viral regulation rather than cellular regulation, it is at new locations because the viral integration machinery is completely specific for the attachment sequence of the virus
27:00
but is not at all specific for the recipient sequences, the target sequences in the cell. There is no homology involved in integration and this is another topic we can discuss later, the cell must be an appropriate cell.
27:20
This has been a special kind of carcinogenesis carried out by special viruses. Such viruses exist in domestic cats where they cause solid tumors in this very rapid fashion.
27:41
Fortunately, such viruses do not exist in man and most cancer in man, as Dr. Choeh indicates in this cartoon, just confirms, arises in a multi-step fashion. Here we are considering a row of normal cells and watching this cohort of cells through time
28:04
where first a single mutation appears and then replicates giving an altered clone of cells, then a second mutation appears giving a further altered clone of cells, now two altered clones, then a third mutation appears
28:21
and somewhere between three and seven, we are not sure of the number, mutations occur and the cell becomes cancerous. So we have two apparently very different kind of processes leading to cancer. But as Dr. Ochoa again told you,
28:41
the same proto-oncogenes are apparently involved. How do we reconcile these differences? Over here we are looking at proto-oncogenes and here at active oncogenes. In the case of carcinogenesis by a highly oncogenic retrovirus,
29:02
the proto-oncogene has been altered through evolution in multiple steps to give a multiply altered product, mutated, fused, differently regulated. So the highly oncogenic retrovirus is able to cause cancer so efficiently
29:22
by adding the already multiply altered gene into the cell DNA. Now in the case of the non-viral cancers, could you focus at the bottom please? In the case of the non-viral cancers,
29:40
again in some cases, proto-oncogenes have been found to be altered, a base pair mutation, an amplification, a translocation. However, in the case of the non-viral cancers, there are several proto-oncogenes,
30:00
each which has been altered one time. And the multi-step process has been the accumulation of one change, a second change, a third change. The multi-step process here took place in time, but because of the nature of the viral vectors,
30:21
all of the changes involved the single gene, the viral oncogene. So we see that the same process is involved in carcinogenesis by highly oncogenic retroviruses and by other kinds of agents.
30:44
There are several genetic changes to normal cell genes which change them into active cancer genes. Thank you.